Sutro Biopharma, Inc. (STRO) has 20 tenedores institucionales e internos conocidos registrados. El mayor tenedor es MOLINA ARTURO MD con 37,500 acciones. Otros tenedores destacados incluyen Freund John Gordon y NEWELL WILLIAM J.
En los últimos 12 meses, los internos han realizado 44 transacciones en STRO acciones — 28 compras (valoradas en $796.23K) y 0 ventas (valoradas en RSU Award). Las compras internas han superado las ventas durante este período, lo que puede señalar confianza en las perspectivas de la empresa.
STRO Participación de Insiders
Principal Titular
MOLINA ARTURO MD
37,500 acciones
Compras (12 meses)
28
$796.23K valor
Ventas (12 meses)
0
$0.00 valor
Actividad de Transacciones (12 meses)
Principales Titulares Internos
| # |
Nombre |
Cargo |
Acciones en Propiedad |
Última Declaración |
Tamaño Relativo |
| 1 |
Molina Arturo Md |
Chief Medical Officer |
37,500 |
2022-03-07 |
|
| 2 |
Freund John Gordon |
Director |
35,000 |
2024-06-10 |
|
| 3 |
Newell William J |
CEO |
31,125 |
2025-03-06 |
|
| 4 |
Worsley Stephen |
Chief Business Officer |
30,000 |
2019-01-31 |
|
| 5 |
Lawlis V Bryan |
Director |
26,033 |
2018-09-27 |
|
| 6 |
Sharp Shalini |
Director |
18,500 |
2022-06-08 |
|
| 7 |
Borgman Anne Elizabeth |
Chief Medical Officer |
17,812 |
2025-05-05 |
|
| 8 |
Shabbir Anik |
Chief Technical Ops. Officer |
17,500 |
2023-03-07 |
|
| 9 |
Leyman Barbara |
Chief Business Officer |
16,056 |
2025-08-26 |
|
| 10 |
Albini Edward C |
CFO and Secretary |
15,750 |
2025-03-04 |
|
| 11 |
Shtylla Brunilda |
Chief Business Officer |
12,928 |
2023-08-28 |
|
| 12 |
Janney Daniel |
Director |
11,610 |
2019-06-19 |
|
| 13 |
Fitzpatrick Linda A |
Chief People & Comm. Officer |
9,125 |
2025-03-06 |
|
| 14 |
Hallam Trevor |
Pres. Rsrch & Cf. Sctific Ofcr |
7,500 |
2023-04-17 |
|
| 15 |
Vasquez Nicki |
Chief Port. Strat & Alnce Ofcr |
6,500 |
2023-07-13 |
|
| 16 |
Srinivasan Venkatesh |
Chief Tech Op Officer |
5,000 |
2025-05-05 |
|
| 17 |
Chow Gregory K. |
CFO |
5,000 |
2026-03-03 |
|
| 18 |
Ross Michael Jay |
10 Percent Owner |
4,315 |
2018-10-01 |
|
| 19 |
Svlsf V, Llc |
10 Percent Owner |
4,315 |
2018-10-01 |
|
| 20 |
Gerber Hans-peter |
Chief Scientific Officer |
2,250 |
2026-03-03 |
|
Transacciones Recientes (últimos 12 meses)
| Fecha |
Nombre |
Cargo |
Tipo |
Acciones |
Precio |
Valor |
| 2026-03-04 |
Pauling David |
Chief Admin. Ofcr. & Gc |
Ejercicio de Opciones (Venta) |
675 |
- |
- |
| 2026-03-04 |
Chung Jane |
Chief Executive Officer |
Ejercicio de Opciones (Venta) |
788 |
- |
- |
| 2026-03-02 |
Pauling David |
Chief Admin. Ofcr. & Gc |
Concesión de RSU |
4,200 |
- |
- |
| 2026-03-01 |
Pauling David |
Chief Admin. Ofcr. & Gc |
Ejercicio de Opciones (Venta) |
500 |
- |
- |
| 2026-03-02 |
Gerber Hans-peter |
Chief Scientific Officer |
Concesión de RSU |
5,000 |
- |
- |
| 2026-03-01 |
Gerber Hans-peter |
Chief Scientific Officer |
Ejercicio de Opciones (Venta) |
1,125 |
- |
- |
| 2026-03-02 |
Chung Jane |
Chief Executive Officer |
Retención Fiscal de RSU |
2,779 |
$20.55 |
$57.11K |
| 2026-03-01 |
Chung Jane |
Chief Executive Officer |
Ejercicio de Opciones (Venta) |
688 |
- |
- |
| 2026-03-02 |
Chow Gregory K. |
CFO |
Concesión de RSU |
5,000 |
- |
- |
| 2025-12-23 |
Pauling David |
Chief Admin. Ofcr. & Gc |
Concesión de RSU |
7,200 |
$10.38 |
$74.74K |
| 2025-12-23 |
Gerber Hans-peter |
Chief Scientific Officer |
Concesión de RSU |
7,925 |
$10.38 |
$82.26K |
| 2025-12-23 |
Hunter Heidi |
Director |
Concesión de RSU |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Chow Gregory K. |
CFO |
Concesión de RSU |
8,200 |
$10.38 |
$85.12K |
| 2025-12-23 |
Dybbs Michael |
Director |
Concesión de RSU |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Wigginton Jon Marc |
Director |
Concesión de RSU |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Jagpal Sukhi |
Director |
Concesión de RSU |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Lobacki Joseph M |
Director |
Concesión de RSU |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Petree Daniel H |
Director |
Concesión de RSU |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Matsui Connie |
Director |
Concesión de RSU |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Panek James P |
Director |
Concesión de RSU |
1,500 |
$10.38 |
$15.57K |
| 2025-12-12 |
Chung Jane |
Chief Executive Officer |
Ejercicio de Opciones (Venta) |
2,500 |
- |
- |
| 2025-10-15 |
Pauling David |
Chief Admin. Ofcr. & Gc |
Compra Informativa |
12,504 |
$0.80 |
$9.99K |
| 2025-10-15 |
Gerber Hans-peter |
Chief Scientific Officer |
Compra Informativa |
17,000 |
$0.80 |
$13.61K |
| 2025-10-15 |
Chung Jane |
Chief Executive Officer |
Compra Informativa |
12,500 |
$0.80 |
$10.01K |
| 2025-10-15 |
Chow Gregory K. |
CFO |
Compra Informativa |
19,750 |
$0.81 |
$16K |